Stock SRNE SORRENTO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Sorrento Therapeutics, Inc.

Equities

SRNE

US83587F2020

End-of-day quote OTC Markets
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
0.0113 USD -22.07% Intraday chart for Sorrento Therapeutics, Inc. +7.62% -90.85%
Apr. 10 Sorrento Therapeutics, Inc. Emerged from Bankruptcy CI
Mar. 15 Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SORRENTO THERAPEUTICS, INC. Stock Sorrento Therapeutics, Inc.
 6.14M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. SRNE Stock
  4. Charts Sorrento Therapeutics, Inc.
  5. Sector Chart